Cortese, Mario
Hagan, Thomas https://orcid.org/0000-0002-5254-5251
Rouphael, Nadine https://orcid.org/0000-0002-2512-7919
Wu, Sheng-Yang
Xie, Xia
Kazmin, Dmitri
Wimmers, Florian https://orcid.org/0000-0002-6482-2228
Gupta, Shakti
van der Most, Robbert https://orcid.org/0000-0002-3065-6946
Coccia, Margherita https://orcid.org/0000-0003-1947-4735
Aranuchalam, Prabhu S. https://orcid.org/0000-0003-0090-5689
Nakaya, Helder I. https://orcid.org/0000-0001-5297-9108
Wang, Yating
Coyle, Elizabeth
Horiuchi, Shu
Wu, Hanchih
Bower, Mary
Mehta, Aneesh
Gunthel, Clifford
Bosinger, Steve E. https://orcid.org/0000-0002-2116-5061
Kotliarov, Yuri https://orcid.org/0000-0002-6558-8883
Cheung, Foo
Schwartzberg, Pamela L. https://orcid.org/0000-0001-6318-9187
Germain, Ronald N. https://orcid.org/0000-0003-1495-9143
Tsang, John https://orcid.org/0000-0003-3186-3047
Li, Shuzhao
Albrecht, Randy https://orcid.org/0000-0003-4008-503X
Ueno, Hideki https://orcid.org/0000-0001-7747-0738
Subramaniam, Shankar
Mulligan, Mark J.
Khurana, Surender https://orcid.org/0000-0002-0593-7965
Golding, Hana
Pulendran, Bali https://orcid.org/0000-0001-6517-4333
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19 AI167903)
Article History
Received: 15 July 2024
Accepted: 11 November 2024
First Online: 2 January 2025
Competing interests
: R.v.d.M., M. Cortese and M. Coccia are or were employees of GSK. B.P. serves or has served on the External Immunology Board of GSK and on the Scientific Advisory Board of Sanofi, Medicago, Boehringer Ingelheim, Pharmajet, Icosavax, Imu Biosciences and Ed-Jen, and holds shares at CircBio and Orbital Therapeutics. R.v.d.M. and T.H. hold shares in the GSK group of companies. The other authors declare no competing interests.